We are devoted to strengthening emerging pharmaceutical markets. To this end, we commit to upholding essential principles in all of our dealings with clients. Our Client Charter is our promise to you that ...
Our Quality Edge is how we blend Empathy, Reliability and Responsiveness to deliver exceptional service to all our clients.
We Partner with Clients to execute Outcomes Research in emerging markets.
We develop results-driven market access solutions for clients in emerging markets.
We are devoted to strengthening emerging pharmaceutical markets.
Market Access Solutions
Innovative Access Strategies
Our Quality Edge
Get your message out to an international audience. Shout Out Campaign. carapinha.com/contact-us-2/ pic.twitter.com/ElqHvvjq34
About a day ago from Carapinha & Company's Twitter
South Africa may ask pharma firms for fee to clear drug review backlog. phrmaccess.com/x/hs pic.twitter.com/BVFDdSLzgJ
About 2 days ago from Carapinha & Company's Twitter
Are China’s drug price controls failing?. phrmaccess.com/x/hl pic.twitter.com/tANp0glrEq
About 3 days ago from Carapinha & Company's Twitter
Facebook Sought Access to Medical Records to Target Pharma Ads. phrmaccess.com/x/hq pic.twitter.com/M05LsUofao
About 4 days ago from Carapinha & Company's Twitter
Towards Greater Access to Generics and Biosimilars. phrmaccess.com/x/hh pic.twitter.com/dXHCveumhi
About 6 days ago from Carapinha & Company's Twitter
MS patients need better access to medicines. phrmaccess.com/x/hg pic.twitter.com/OR3orqMIJK
Last week from Carapinha & Company's Twitter
Senators launch probe into why price of cancer drug increased 1400 percent. phrmaccess.com/x/ha pic.twitter.com/16cZWGQHoo
Get your message out to an international audience. Shout Out Campaign. carapinha.com/contact-us-2/ pic.twitter.com/JL3KmWnoFg
Frustration Over Generic Drug Shortages and Prices Prompts Federal and Private Actions. phrmaccess.com/x/he pic.twitter.com/Q4DEXPy7vr
As antibiotics fail, global consumption of antibiotics skyrockets, further driving drug resistance. phrmaccess.com/x/h6 pic.twitter.com/y8w88XsFdd
FDA working on a ‘dozen’ policies to boost copycat biotech drugs. phrmaccess.com/x/gw pic.twitter.com/1bbq7YuzwQ
About 2 weeks ago from Carapinha & Company's Twitter